<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://www.openstarts.units.it:80/dspace/handle/10077/6827">
    <title>DSpace Collection: University of Trieste, 25-26.5.2012</title>
    <link>http://www.openstarts.units.it:80/dspace/handle/10077/6827</link>
    <description>University of Trieste, 25-26.5.2012</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://www.openstarts.units.it:80/dspace/handle/10077/6830" />
      </rdf:Seq>
    </items>
    <dc:date>2013-06-20T01:45:50Z</dc:date>
  </channel>
  <item rdf:about="http://www.openstarts.units.it:80/dspace/handle/10077/6830">
    <title>New Antimicrobials Project 2nd Workshop : New Compounds &amp; New Strategies for Antimicrobials, University of Trieste, 25-26.5.2012</title>
    <link>http://www.openstarts.units.it:80/dspace/handle/10077/6830</link>
    <description>Title: New Antimicrobials Project 2nd Workshop : New Compounds &amp; New Strategies for Antimicrobials, University of Trieste, 25-26.5.2012
Abstract: Antibacterial resistance is spreading globally at an alarming rate and continues to&#xD;
increase. New potent antibacterial agents and therapies are therefore continually&#xD;
needed. In recent years, new antibacterial compounds have mainly been additions to&#xD;
the existing classes of drugs and truly new structures have rarely been developed.&#xD;
Pharmaceutical industry has little interest in developing new structures due to high&#xD;
investment and low profit expectancy. The derivatives of existing drugs however&#xD;
raise bacterial resistance much faster than completely new compounds. To overcome&#xD;
the chronic problem of antibiotic resistance, totally new compounds and approaches&#xD;
are required, involving collaboration of researchers from various disciplines, as well&#xD;
as high societal investments.&#xD;
The NAM (New Antimicrobials) Project is funded by the Marie Curie Actions of&#xD;
the EU Seventh Framework Programme. The aim was to foster collaboration and&#xD;
exchange of personnel between academic groups and companies working on various&#xD;
aspects of antimicrobials: new sources, new approaches and mode-of action. This is&#xD;
the second Workshop organised within the NAM project and its aim is to coalesce the&#xD;
experience of NAM project members with that of participants from other academic&#xD;
and industry groups.
Type: Libro / capitolo</description>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

